Trademark Overview
On Tuesday, May 14, 2024, a trademark application was filed for KALDENN with the United States Patent and Trademark Office. The USPTO has given the KALDENN trademark a serial number of 79403077. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 29, 2024. This trademark is owned by NAOGEN PHARMA. The KALDENN trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:
Radiopharmaceutical products; radioactive products for medical use; radioactive substances for medical use; isotopes for medical use; radiopharmaceutical preparations for medical use made from radiopharmaceutical generators [apparatus]; diagnostic radiopharmaceutical preparations; reagents and substances for medical diagnostic purposes; diagnostic biomarking reagents for medical use; contrast products for medical imaging; cardiovascular medicines used in myocardial infarction treatment; contrast agents for molecular imaging for medical use.
Chemical substances, chemical materials and chemical products for use in medicine production; chemical substances, chemical preparations and chemical products for use in radiopharmaceutical product manufacture and production; active chemical ingredients for use in manufacture and production of radiopharmaceutical products against cancer; diagnostic preparations for scientific use or for research; diagnostic reagents for scientific use or for research; radioactive preparations for laboratory use; contrast agents for molecular imaging other than for medical use; rubidium; strontium.
Radiopharmaceutical generators [apparatus] for medical use; radioactive and radiopharmaceutical product generators [apparatus] for medical use; rubidium-82 generators [apparatus] for medical use; injectors for medical use; radiopharmaceutical medicine injectors; radioactive and radiopharmaceutical product injectors for medical use; automatic injectors for administering radiopharmaceutical products; injectors of rubidium-82 to patients for medical use; magnetic resonance tomography apparatus; computerized tomography apparatus; tomographic scanners for nuclear medicine; medical apparatus for diagnosing suspected heart attacks.